Available at Pre- and Post-Master’s Levels
Pre-Master’s Certificate in Global Pharmacovigilance: Benefit-Risk Assessment
Regulated industry is challenged with providing oversight of a product’s safety throughout its lifecycle. Reviewing safety profiles and managing and assessing benefit and risk that arise during and after development are constant concerns. This certificate provides a foundation in pharmacovigilance principles to both experienced professionals and those seeking entry into this career field from within and outside the pharmaceutical area.
This five-course program provides a solid scientific and regulatory foundation in the key disciplines necessary for a successful career in the field.
The required courses include:
- Post-Marketing Safety Surveillance (5571) or Clinical Drug Safety and Pharmacovigilance (5538)
- Good Pharmacovigilance Operations (5508)
- Pharmacoepidemiology (5573)
- Regulatory and Legal Basis of Pharmacovigilance (5579)
- Risk Management and Safety Signaling of Healthcare Products (5578)
Students have four years to complete the Certificate in Global Pharmacovigilance: Benefit-Risk Assessment and must maintain an overall B average.
Notice of Completion
Post-Master’s Certificate in Global Pharmacovigilance: Benefit-Risk Assessment
Students who have received the M.S. in RAQA are eligible to complete the Post-Master’s Certificate in Global Pharmacovigilance: Benefit-Risk Assessment. Courses taken for the completion of the M.S. degree will not be counted towards the Post-Master’s Certificate in Global Pharmacovigilance: Benefit-Risk Assessment. Students need to take five additional courses beyond the M.S. to receive the additional certificate in Global Pharmacovigilance: Benefit-Risk Assessment. This certificate is open to students who received their master's degrees from other schools. These individuals must complete five courses. For more information, click here.